Difficulty: Medium
Average Score: 95%
Practice
A 24-year-old man with Hodgkin├óÔé¼Ôäós lymphoma presents to the emergency department with chest pain for the past 2 days. An electrocardiogram shows nonspecific changes. An echocardiogram is performed that shows dilation of the left ventricle, and the diagnosis of dilated cardiomyopathy is made. He has been receiving chemotherapy for Hodgkin├óÔé¼Ôäós lymphoma over the last month. What medication is most likely responsible for his cardiomyopathy?
Correct answer
D
Rationale
In this case, the most likely chemotherapy drug responsible for the patient's dilated cardiomyopathy is Doxorubicin (Option D). Doxorubicin belongs to a class of drugs known as anthracyclines, which are well-documented to cause cardiotoxicity. Anthracycline-induced cardiomyopathy is a serious side effect that can lead to heart failure. Doxorubicin causes damage to the heart muscle cells, leading to the dilation of the left ventricle seen in this patient's echocardiogram.
Regarding the other options:
A) Bleomycin is known for causing pulmonary toxicity, not cardiomyopathy.
B) Cisplatin is not commonly associated with cardiomyopathy but can cause kidney damage and hearing loss.
C) Dactinomycin is associated with pulmonary fibrosis, not cardiomyopathy.
Educational Context:
Understanding the side effects of chemotherapy drugs is crucial for healthcare providers, especially those working with cancer patients. This case highlights the importance of monitoring patients receiving anthracyclines for potential cardiotoxicity. It also underscores the need for healthcare professionals to be aware of the specific side effects associated with different chemotherapy drugs to provide optimal patient care.
Regarding the other options:
A) Bleomycin is known for causing pulmonary toxicity, not cardiomyopathy.
B) Cisplatin is not commonly associated with cardiomyopathy but can cause kidney damage and hearing loss.
C) Dactinomycin is associated with pulmonary fibrosis, not cardiomyopathy.
Educational Context:
Understanding the side effects of chemotherapy drugs is crucial for healthcare providers, especially those working with cancer patients. This case highlights the importance of monitoring patients receiving anthracyclines for potential cardiotoxicity. It also underscores the need for healthcare professionals to be aware of the specific side effects associated with different chemotherapy drugs to provide optimal patient care.